CCR5 was reported to be associated with poor overall survival in breast cancer [34], poor relapse-free survival in prostate cancer [68], high histological grade in pancreatic cancer [35], and perineural invasion in salivary adenoid cystic carcinoma [36]. This evidence concerns the gene CCR5 and pancreatic neoplasm.